FSD201

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)NCT05652907Quantum BiopharmaPhase 2Terminated2023-05-24Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.